Skip to main content

Table 2 Demographics characteristics of vitiligo patients

From: TLR4 gene polymorphisms in Egyptian vitiligo patients: insights into emerging association with clinical activity, family history, and response to therapy

  Case Control
Age/Years (MEAN ±SD)
Group 1 (< 18 years) (MEAN ± SD)
Group 2 (> 18 years) (MEAN ± SD)
33.23 ± 16.98
11.87 ± 4.14
39.97 ± 13.54
33.86 ± 15.9
12.37 ± 4.52
38.90 ± 13.18
Age of Onset/ Years (MEAN ± SD) 26.04 ± 14.83  
Gender Male (N/%) 45/45%  
Female (N/%) 55/55%  
Course of disease Regressive (N/%) 6/6%  
Progressive (N/%) 90 /90%  
Stable (N/%) 4/4%  
Psychic trauma Yes (N/%) 26 /26%  
No (N/%) 74/74%  
Autoimmune diseases (AIDs) Yes (N/%) 0/0%  
No (N/%) 100/100%  
Alopecia Yes (N/%) 14/14%  
No (N/%) 86/86%  
Family history Yes (N/%) 8/8%  
No (N/%) 92/92%  
Family history of AIDs Yes (N/%) 9/9%  
No (N/%) 91/91%  
Remission Yes (N/%) 63/63%  
No (N/%) 37/37%  
Phototherapy Yes (N/%) 99/99%  
No (N/%) 1/1%  
Type Segmental (N/%) 17/17%  
Non-Segmental (N/%) 83/83%  
VIDA score 0 22/22%  
1 13/13%  
2 14/14%  
3 15/15%  
4 36/36%  
  1. SD standard deviation